Soros Fund Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-864,009
Closed -$87.7M 289
2025
Q4
$87.7M Buy
+864,009
New +$69.4M 1.02% 26
2025
Q1
Sell
-496,938
Closed -$27.9M 229
2024
Q4
$27.9M Buy
496,938
+118,348
+31% +$7.36M 0.42% 65
2024
Q3
$25.8M Buy
378,590
+153,590
+68% +$8.67M 0.37% 63
2024
Q2
$9.51M Buy
+225,000
New +$12.4M 0.17% 117
2020
Q2
Sell
-8,300
Closed -$481K 156
2020
Q1
$481K Buy
+8,300
New +$674K 0.02% 111
2014
Q2
Sell
-200,000
Closed -$2.83M 391
2014
Q1
$2.83M Buy
+200,000
New +$2.7M 0.03% 217

Other funds holding EXAS

Soros Fund Management's EXAS Position: Q1 2026 in Review

Soros Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 864,009 shares — an estimated $87.7M sold.

Soros Fund Management first reported a position in EXAS in Q1 2014 and held it in 6 quarters. The position peaked at $87.7M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Soros Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Soros Fund Management sold 864,009 Exact Sciences shares in Q1 2026, an estimated $87.7M.
  • Soros Fund Management first reported a position in Exact Sciences in Q1 2014 and held it in 6 quarters.
  • Soros Fund Management's Exact Sciences position peaked at $87.7M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Soros Fund Management's 13F filing for Q1 2026, filed 15 May 2026.